大唐药业
(836433)
| 流通市值：12.80亿 | | | 总市值：19.35亿 |
| 流通股本：1.69亿 | | | 总股本：2.56亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 45,426,052.56 | 207,449,553.2 | 158,063,006.9 | 105,570,020.1 |
| 营业收入 | 45,426,052.56 | 207,449,553.2 | 158,063,006.9 | 105,570,020.1 |
| 二、营业总成本 | 44,064,489.37 | 202,679,425.51 | 144,641,833.1 | 98,567,111.55 |
| 营业成本 | 16,610,676.04 | 63,236,619.9 | 44,001,487.45 | 27,230,503.64 |
| 税金及附加 | 315,640.09 | 4,765,367.85 | 1,978,667.31 | 1,700,468.96 |
| 销售费用 | 15,867,201.24 | 87,148,533.84 | 64,189,993.11 | 49,847,319.88 |
| 管理费用 | 9,593,947.56 | 36,677,156.2 | 28,613,585.06 | 16,850,779.6 |
| 研发费用 | 1,469,694.17 | 9,473,311.35 | 6,429,607.81 | 3,738,021.21 |
| 财务费用 | 207,330.27 | 1,378,436.37 | -571,507.64 | -799,981.74 |
| 其中:利息费用 | 591,546.94 | 1,696,496.5 | 355,267.37 | 355,267.37 |
| 其中:利息收入 | 391,478.28 | 332,891.21 | 1,168,780.99 | 1,162,862.86 |
| 加:公允价值变动收益 | 12,937.8 | 123,995.34 | 123,995.34 | 123,995.34 |
| 加:投资收益 | - | 1,827,592.97 | 88,397.44 | 66,900.05 |
| 资产减值损失(新) | -303,726.79 | -2,761,471.02 | -1,649,734.38 | -844,663.33 |
| 信用减值损失(新) | -558,499.03 | -479,014.93 | -3,702,888.55 | -2,812,215.72 |
| 其他收益 | 1,031,718.95 | 8,318,433.47 | 3,942,157.5 | 2,140,100.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,543,994.12 | 11,799,663.52 | 12,223,101.15 | 5,677,025.42 |
| 加:营业外收入 | 110,000 | 1,589,719.19 | 518,501.08 | 518,501 |
| 减:营业外支出 | - | 38,080 | - | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,653,994.12 | 13,351,302.71 | 12,741,602.23 | 6,195,526.42 |
| 减:所得税费用 | 365,112.82 | 2,814,808.71 | 2,364,797.08 | 1,054,613.07 |
| 六、净利润 | 1,288,881.3 | 10,536,494 | 10,376,805.15 | 5,140,913.35 |
| 持续经营净利润 | 1,288,881.3 | 10,536,494 | 10,376,805.15 | 5,140,913.35 |
| 归属于母公司股东的净利润 | 1,288,881.3 | 10,536,494 | 10,376,805.15 | 5,140,913.35 |
| (一)基本每股收益 | 0.01 | 0.04 | 0.04 | 0.02 |
| (二)稀释每股收益 | 0.01 | 0.04 | 0.04 | 0.02 |
| 九、综合收益总额 | 1,288,881.3 | 10,536,494 | 10,376,805.15 | 5,140,913.35 |
| 归属于母公司股东的综合收益总额 | 1,288,881.3 | 10,536,494 | 10,376,805.15 | 5,140,913.35 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-14 |
| 审计意见(境内) | | 标准无保留意见 | | |